October Pharma S.A.E (OCPH.CA)

Also known as:  OP, October Pharma
Data delayed by 15 minutes
100.00 EGP 0.000.00%
As of 26 FEB 2020 - GMT|Egypt SE

OP Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
1.35%
P/E (Last 12 Month)
15.562
Upside
-
Target Price (Mean)
-
52Wk
59.41 02 JAN
100.0 25 FEB

Open
Data not available
Previous Close
100.00 EGP
Turnover
Data not available
EPS
6.416 EGP
Volume
0
Transactions
0
Market Cap
600.00M EGP
IPO Date
11-Jul-2002
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About October Pharma S.A.ELast updated on: 22 February 2018

Business Summary
Production of branded drugs and multi-vitamins.
Country of Incorporation
Ownership Type
Established In
1987
Primary Sector
Number of Employees
800
Stock Listing
IDStock TypeCurrencyExchangeSymbol
OCPH.CASEOrdinaryEGPEgypt SEOCPH

Contact details

Primary address
October Pharma S.A.E. Building
Street 25
First Industrial Zone, Plot 190
38
Egypt
6th of October City
12566
CONTACT
  • Tel: +20 2-3833-0329
  • Tel: +20 2-3833-0652
  • Tel: +20 2-3833-1832
  • Fax: +20 2-3833-0653
  • Email: www.octoberpharma.com
Region
Giza
More

Takeda celebrates anniversary with brand-new address

The new Area offices based at One Central at Dubai World Trade Centre is recognized for its green credentials, achieving Gold level certification by LEED standards, with Takeda's offices receiving Silver level certification

Press Release - Sunday 9 August 2020
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Dr Ahmad Zaghloul Ahmad Mustafa
Managing Director
Dr Wafaa Raafat Gafar
General Manager, Factory
Mr Mohammed Nasib Abdullah Farid
Engineering Director

Board Members

Dr Fouad Mohammed Mohammed El Lafy
Chairman
Dr Ahmad Zaghloul Ahmad Mustafa
Director representing Arab Company for Drug Industries & Medical Appliances
Mr Shaaban Mohammed Mohammed
Director representing Joint Arab Investment Corporation
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
ADVANCED PHARMA2.330 EGP0.00
EGYPT INTL PHRM49.000 EGP0.00
ARAB PHARM63.990 EGP0.00
ALX. PHARMACEUT.135.380 EGP0.00
CLEOPATRA HOSP4.970 EGP0.00
MEDICAL PACK1.965 EGP0.00
More

Monday Outlook: Asian stocks cautious; dollar holds gains

Monday Outlook: Asian stocks cautious; dollar holds gains

Gold steady on virus fears; oil on the rise on U.S. stimulus hopes

More

Most Viewed Stocks

Stock Screener

More